Antimicrobial Susceptibility of Bacterial Isolates from Domestic Dogs with Urinary Tract Infection

세균성 요로 감염증 애완견의 세균 분포 및 항생제 감수성

  • Choi, Dae-Young (College of Veterinary Medicine, Korea Zoonoses Research Institute, Chonbuk National University) ;
  • Choi, Dae-Sung (College of Veterinary Medicine, Korea Zoonoses Research Institute, Chonbuk National University) ;
  • Jang, Hyung-Kwan (College of Veterinary Medicine, Korea Zoonoses Research Institute, Chonbuk National University) ;
  • Song, Hee-Jong (College of Veterinary Medicine, Korea Zoonoses Research Institute, Chonbuk National University) ;
  • Cho, Jeong-Gon (College of Veterinary Medicine, Korea Zoonoses Research Institute, Chonbuk National University)
  • 최대영 (전북대학교 수의과대학.인수공통전염병연구소) ;
  • 최대성 (전북대학교 수의과대학.인수공통전염병연구소) ;
  • 장형관 (전북대학교 수의과대학.인수공통전염병연구소) ;
  • 송희종 (전북대학교 수의과대학.인수공통전염병연구소) ;
  • 조정곤 (전북대학교 수의과대학.인수공통전염병연구소)
  • Published : 2010.02.28

Abstract

Bacterial pathogens were isolated from dogs with urinary tract infection (UTI) in local animal hospitals between August 2003 and December 2009. Bacteria were isolated from urine of 47 dogs. The isolated pathogens were Escherichia coli (n = 27), Streptococcus spp. (n = 7), Staphylococcus spp. (n = 5), Enterobacter spp. (n = 3), Proteus spp. (n = 2), other species were 3 strains, respectively. E. coli were susceptible to imimpenem, polymyxin B, amikacin, cephalosporins, aztreonam, amoxicillin clavulate, cephalosporins, tricarcillin, and amoxicillin clavulate, while were resistant bacitracin, erythromycin, lincomycin, oxacillin, penicillin, and novobiocin. Streptococcus spp. were susceptible to bacitracin, imimpenem, and trimethoprime-sulfa, while were highly resistant amikacin, cefotaxim, cefoxitin, cloxacillin, gentamicin, lincomycin, oxacillin, penicillin, streptomycin, and tobramycin. Staphylococcus spp. were susceptible to cefoxitin, doxycycline, enrofloxacin, imimpenem, and tobramycin, but were resistant aztreonam and tetracycline.

2003년부터 2009년까지 서울 지역 동물병원에 의뢰된 세균성 요로 감염증 개의 병소에서 세균의 분리빈도와 항생제 감수성을 조사한 결과는 다음과 같다. 세균성 요로 감염증 개의 뇨에서 Escherchia coli 27주, Streptoococcus spp. 7주, Staphylococcus spp. 5주, Enterobacter spp. 3주, Proteus spp. 2주, 그리고 기타 세균 3주, 총 47주의 세균이 분리되었다. 이 중 분리 빈도가 높은 E. coli, Streptoococcus spp. 및 Staphylococcus spp.를 대상으로 항생제 감수성을 조사하였다. E. coli의 항생제 감수성은 imimpenem, polymyxin B, amikacin, cephalosporins, aztreonam, amoxicillin clavulate, cephalosporins, tricarcillin, amoxicillin clavulate 순으로 나타난 반면 bacitracin, erythromycin, lincomycin, oxacillin, penicillin, novobiocin 등에 대해서는 높은 내성을 나타내었다. Streptoococcus spp.의 항생제 감수성은 bacitracin, imimpenem, trimethoprime-sulfa 순이었고 amikacin, cefotaxim, cefoxitin, cloxacillin, gentamicin, lincomycin, oxacillin, penicillin, streptomycin, tobramycin에는 매우 높은 내성을 나타내었다. Staphylococcus spp.의 항생제 감수성은 cefoxitin, doxycycline, enrofloxacin, imimpenem, tobramycin에 매우 높았고 aztreonam, tetracycline에 내성을 나타내었다.

Keywords

References

  1. Atlas RM, Parks LC. Handbook of microbiological media. CRC Press, Inc, Boca Raton Florida 1993: 136-138, 533-535.
  2. Baggot JD, Ling GV, Ronald CC. Clinical pharmacokinetics of amikacin in dogs. Am J Vet Res 1985; 46: 1793-1796.
  3. Bartges JW. Diagnosis of urinary tract infections. Vet Clin North Am Small Anim Pract 2004; 34: 923-933. https://doi.org/10.1016/j.cvsm.2004.03.001
  4. Bartges JW. Urinary tract infections. In: Veterinary internal medicine, 6 ed, Elsevier Saunders Co, St. Louis 2005: 1800- 1808.
  5. Blondeau JM, Tillotson GS. Formula to help select rational antimicrobial therapy (FRAT): Its application to communityand hospital-acquired urinary tract infections. Int J Antimicrob Agents 1999; 12: 145-150. https://doi.org/10.1016/S0924-8579(98)00107-1
  6. Cetin C, Senturk S, Kocabiyik AL, Temizel M, Ozel E. Bacteriological examination of urine samples from dogs with symptoms of urinary tract infection. Turk J Vet Anim Sci 2003; 27: 1225-1229.
  7. Drazenovich N, Ling GV, Foley J. Molecular investigation of Escherichia coli strains associated with apparently persistent urinary tract infection in dogs. J Vet Intern Med 2004; 18: 301-306.
  8. Feria C, Ferreira E, Correia JD, Gonalves J, Cania M. Patterns and mechanisms of resistance to beta-lactams and betalactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal. J Antimicrob Chemother 2002; 49: 77-85. https://doi.org/10.1093/jac/49.1.77
  9. Franklin A, Moerner AP. Antibiotic sensitivity of bacterial isolates from urinary tract infections and metritis in dogs. Compend Contin Educ Pract Vet 1996; 18: 96.
  10. Ganiere JP, Medaille C, Mangion C, Antimicrobial drug susceptibility of Staphylococcus intermedius isolated from canine pyodermas. J Vet Med B 2005; 52: 25-31. https://doi.org/10.1111/j.1439-0450.2004.00816.x
  11. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated communityacquired urinary tract infections. Review. Ann Intern Med 2001; 135: 41-50. https://doi.org/10.7326/0003-4819-135-1-200107030-00012
  12. Johnson JR, Clabots C. Sharing of virulent Escherichia coli clones among household members of a woman with acute cystitis. Clin Infect Dis 2006; 43: E101-108. https://doi.org/10.1086/508541
  13. Johnson JR, Kaster N, Kuskowski MA, Ling GV. Identification of urovirulence traits in Escherichia coli by comparison of urinary and rectal E. coli isolates from dogs with urinary tract infection. J Clin Microbiol 2003; 41: 337-345. https://doi.org/10.1128/JCM.41.1.337-345.2003
  14. Kahlmeter G. The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogensinterim report. J Antimicrob Chemother 2000; 46: 15-22. https://doi.org/10.1093/jac/46.suppl_1.15
  15. Kania SA, Williamson NL, Frank LA, Wilkes RP, Jones RD, Bemis DA. Methicillin resistance of staphylococci isolated from the skin of dogs with pyoderma. Am J Vet Res 2004; 65: 1265-1268. https://doi.org/10.2460/ajvr.2004.65.1265
  16. Kingore WR, Simmons RD. Jackson JW. $\beta$-Lactamase inhibition: a new approach in overcoming bacterial resistance. Compend Contin Educ Pract Vet 1986: 8: 325-331.
  17. Koneman EW, Allen SD, Dowell VR Jr, Janda WM, Sommers HM, Winn WC Jr. Color atlas and textbook of diagnostic microbiology. 3 eds, JB Lippincott Co, Philadelphia 1988: 89-242, 311-392, 473-533.
  18. Kurazono H, Nakano M, Yamamoto S, Ogawa O, Yuri K, Nakata K, Kimura M, Makino S, Nair GB. Distribution of the usp gene in uropathogenic Escherichia coli isolated from companion animals and correlation with serotypes and sizevariations of the pathogenicity island. Microbiol Immunol 2003; 47: 797-802.
  19. Less GE, Rogers KS. Treatment of urinary tract infections in dogs and cats. J Am Vet Med Assoc 1986; 189: 648-652.
  20. Ling GV, Norris CR, Franti CE, Eisele PH, Johnson DL, Ruby AL, Jang SS. Interrelations of organism prevalence, specimen collection method, and host age, sex, and breed among 8,354 canine urinary tract infections (1969-1995). J Vet Intern Med 2001; 15: 341-347.
  21. Ling GV. Therapeutic strategies involving antimicrobial treatment of the canine urinary tract. J Am Vet Med Assoc 1984; 185: 1162-1164.
  22. Low DA, Braaten BA, Ling GV, Johnson DL, Ruby AL. Isolation and comparison of Escherichia coli strains from canine and human patients with urinary tract infections. Infect Immun 1988; 56: 2601-2609.
  23. Normand EH, Gibson NR, Reid SW, Carmichael S, Taylor DJ. Antimicrobial-resistance trends in bacterial isolates from companion-animal community practice in the UK. Prev Vet Med 2000a; 46: 267-278. https://doi.org/10.1016/S0167-5877(00)00149-5
  24. Normand EH, Gibson NR, Taylor DJ, Carmichael S, Reid SW. Trends of antimicrobial resistance in bacterial isolates from a small animal referral hospital. Vet Rec 2000b; 146: 151-155. https://doi.org/10.1136/vr.146.6.151
  25. Murray PR, Forrest KV, Baron EJ, Jorgensen JH, Baron EJ, Yolken RH, Pfaller MA. Manual of clinical microbiology, 8th ed. St. Louis, Missouri: ASM Pr, 2003: 2: 113.
  26. Norris CR, Williams BJ, Ling GV, Franti CE, Johnson, Ruby AL. Recurrent and persistent urinary tract infections in dogs: 383 cases (1969-1995). J Am Anim Hosp Assoc 2000; 36(6): 484-492.
  27. Petersen AD, Walker RD, Bowman MM, Schott HC 2nd, Rosser EJ Jr. Frequency of isolation and antimicrobial susceptibility patterns of Staphylococcus intermedius and Pseudomonas aeruginosa isolates from canine skin and ear samples over a 6-year period (1992-1997). J Am Anim Hosp Assoc 2002; 38: 407-413.
  28. Plumb DC. Veterinary drug handbook. 4 eds, Iowa State Press, Ames, Iowa 2002: 447-449.
  29. Prescott JF, Baggot JD. Antimicrobial Therapy in Veterinary Medicine, 2 eds, Iowa State University Press, Ames 1993: 21-292.
  30. Prescott JF, Hanna WJ, Reid-Smith R, Drost K. Antimicrobial drug use and resistance in dogs. Can Vet J 2002; 43: 107-116.
  31. Seguin MA, Vaden SL, Altier C, Stone E, Levine JF. Persistent urinary tract infections and reinfections in 100 dogs (1989-1999). J Vet Intern Med 2003; 17: 622-631.
  32. Thomsen MK, Svane LC, Poulsen PH. Canine urinary tract infections. Detection, prevalence and therapeutic consequences of bacteriuria. Nord Vet Med 1986; 38: 394-402.
  33. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999; 29: 745-758. https://doi.org/10.1086/520427